Nellie McDaniel

Dr. Nellie McDaniel


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 October 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
BCBridget Crossman
Bridget Crossman
RHRegan Lisa Harmon
Regan Lisa Harmon
KKKourtney Lynn Kostecki
Kourtney Lynn Kostecki
NMNellie McDaniel
Nellie McDaniel
MIMari Iida
Mari Iida
DWDeric L Wheeler
Deric L Wheeler
Head and neck squamous cell carcinoma (HNSCC) is diagnosed in more than 71,000 patients each year in the United States, with nearly 16,000 associated deaths. One significant hurdle in the treatment of HNSCC is acquired and intrinsic resistance to existing therapeutic agents. Over the past several decades, the University of Wisconsin has formed a multidisciplinary team to move basic scientific discovery along the translational spectrum to impact the lives of HNSCC patients. In this review, we outline key discoveries made throughout the years at the University of Wisconsin to deepen our understanding of therapeutic resistance in HNSCC and how a strong, interdisciplinary team can make significant advances toward improving the lives of these patients by combatting resistance to established therapeutic modalities. We are profoundly grateful to the many scientific teams worldwide whose groundbreaking discoveries, alongside evolving clinical paradigms in head and neck oncology, have been instrumental in making our work possible.